Robert E. Hoffman

Robert E. Hoffman (chief executive) discloses dealings in 2 companies, chiefly Esperion Therapeutics, Inc. and TuHURA Biosciences, Inc./NV. In total, 6 filings cover trades dated from 15 February 2022 to 13 July 2026.

On the market, this insider has only ever bought: 1 purchase, €23k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants.

The newest entry dates from 13 July 2026: a transaction, in Esperion Therapeutics, Inc. The last purchase on record was published on 17 February 2022, which is 1,710 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.